Skip common site navigation and headers
United States Environmental Protection Agency
Endocrine Disruptor Research Initiative
Contact Us | Print Version Search: NCER Advanced Search
Begin Hierarchical Links EPA Home > Table2.NCI >  59706-02 Pancreatic Cancer Case Control Study in San Francisco End Hierarchical Links End Hierarchical Links

 

EDRI Federal Project Inventory:
59706-02 Pancreatic Cancer Case Control Study in San Francisco



  1. Sponsor Organization: NIH/NCI

  2. Project Title: 59706-02 PANCREATIC CANCER CASE CONTROL STUDY IN SAN FRANCISCO

  3. Project Focus: HUMAN HEALTH EFFECTS

  4. Description: The investigator propose a population-based, case-control study in men and women to examine hypotheses linkingadenocarcinoma of the exocrine pancreas and detailed occupational history and chemical exposures (in particularchlorinated hydrocarbons and aromatic amines), diet, cigarette smoking, allergies, and other factors. A molecular geneticstudy of polymorphisms at the CYP2D6 gene locus will be conducted to investigate the possible role of genetic riskfactors in the metabolism of cigarette-derived chemical carcinogens in pancreatic cancer risk. The study will include allpatients with adenocarcinoma of the exocrine pancreas who are between the ages of 21 and 85, who speak English orSpanish, and who live in the six-county San Francisco Bay Area at time of diagnosis. 1000 cases and 1150 controlswill be interviewed during the 3.5 year case- ascertainment period. Ongoing rapid case ascertainment methods, usinghospital discharge lists and pathology laboratories, will be employed to locate pancreatic cancer patients in the studyarea within two weeks of diagnosis. Pathology slides for patients will be reviewed by a senior pathologist at theUniversity of California San Francisco (UCSF). Controls will be identified using random digit dial and will befrequency matched to cases by sex and 5-year age group. Two controls for each black and Hispanic patient will beobtained to achieve adequate statistical power and one control will be obtained for each of the other patients. Controlsover age 65 years will be randomly selected from the rolls of the Health Care Financing Administration in addition tothose chosen from the general population. Structured personal interviews will be conducted by trained interviewers instudy subjects' homes or at a place convenient to the subject. Interview topics will include: detailed information onoccupations and chemical and industrial exposures, diet, medical and allergy history, medication use, family history orpancreatic cancer and other relevant conditions, demographic and other factors. Blood samples for genetic investigationwill be drawn by phlebotomists in the subjects' homes. Serum will be stored in aliquots at -40 degrees and cell sampleswill be stored frozen with liquid nitrogen in the Irwin Memorial Blood Bank. Whole blood specimens also will bestored for future genetic and biomarker studies. Analyses will be conducted using univariate and multivariate statisticswith careful attention paid to potential confounders.

  5. References:

  6. Category: MEASUREMENTS

  7. Subcategory: EXPOSURE AND RISK MODELS

  8. Keywords for Experimental System/Species: HUMAN, FIELD STUDY

  9. Keywords for Experimental Endpoints: RISK FACTORS, EPIDEMIOLOGY , CARCINOGENESIS, CYTOCHROME P450

  10. Chemical Agents: CHLORINATED HYDROCARBONS, AROMATIC AMINES

  11. Performing Institution: UNIVERSITY OF CALIFORNIA SAN FRANCISCO

  12. Contact: CONTRACT PERSON: ELAINE C. LEE; BUILDING 31; 11A21; NATIONAL CANCER INSTITUTE, NIH,BETHESDA, MD 20892-2590; 301-496-5515; LEEE@OD.NCI.NIH.GOV


 

 
Begin Site Footer